{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:11:11Z","timestamp":1768486271478,"version":"3.49.0"},"reference-count":35,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2007,1,1]]},"DOI":"10.1185\/030079907x242629","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T00:26:29Z","timestamp":1201134389000},"page":"3123-3130","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy and tolerability of a combined moxifloxacin\/dexamethasone formulation for topical prophylaxis and reduction of inflammation in phacoemulsification: a comparative, double masked clinical trial"],"prefix":"10.1185","volume":"23","author":[{"given":"Lincoln","family":"Lemes Freitas","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Escola Paulista de Medicina, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Soriano","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Escola Paulista de Medicina, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Muccioli","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Escola Paulista de Medicina, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Luisa H\u00f6fling-Lima","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Escola Paulista de Medicina, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Rubens","family":"Belfort","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Escola Paulista de Medicina, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2007,11,1]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.01.025"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2006.10.022"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.07.014"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2005.05.020"},{"key":"CIT0005","doi-asserted-by":"crossref","unstructured":"Lundstrom M, Wejde G, Stenevi U, et al. Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology 2007;114:866\u201370 [Epub ahead of print 26 Feb 2007]","DOI":"10.1016\/j.ophtha.2006.11.025"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2006.01276.x"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.02.051"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.05.011"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ohc.2006.07.005","volume":"19","author":"Ou JI","year":"2006","journal-title":"Ophthalmol Clin North Am"},{"key":"CIT0010","doi-asserted-by":"crossref","unstructured":"Gordon-Bennett P, Karas A, Flanagan D, et al. A survey of measures used for the prevention of postoperative endophthalmitis after cataract surgery in the United Kingdom. Eye 2006 [Epub ahead of print 15 Dec 2006]","DOI":"10.1038\/sj.eye.6702675"},{"key":"CIT0011","doi-asserted-by":"crossref","unstructured":"Arbisser LB. Safety of intracameral moxifloxacin for endophthalmitis prophylaxis during cataract surgery. Accepted for presentation at the American Society of Cataract and Refractive Surgery, April 2007, San Diego, CA, USA","DOI":"10.1016\/j.jcrs.2008.03.017"},{"key":"CIT0012","doi-asserted-by":"crossref","unstructured":"Espiritu CR, Caparas VL, Bolinao JG. Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients. J Cataract Refract Surg 2007;33: 63\u20138","DOI":"10.1016\/j.jcrs.2006.09.019"},{"key":"CIT0013","unstructured":"Arshinoff SA. Advantages and use of intracameral moxifloxacin for bacterial prophylaxis in cataract surgery. Accepted for presentation at the American Society of Cataract and Refractive Surgery, April 2007, San Diego, CA, USA"},{"key":"CIT0014","first-page":"4","volume":"12","author":"El-Harazi SM","year":"2001","journal-title":"Control of intra-ocular inflammation associated with cataract surgery. Curr Opin Ophthalmol"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1097\/00055735-200102000-00011"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.12.1380"},{"key":"CIT0017","first-page":"421","volume":"78","author":"Herbort CP","year":"2000","journal-title":"Diclofenac drops to treat inflammation after cataract surgery. Acta Ophthalmol Scand"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(04)80113-9"},{"key":"CIT0019","first-page":"39","volume":"123","author":"Hariprasad SM","year":"2005","journal-title":"5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Arch Ophthalmol"},{"key":"CIT0020","doi-asserted-by":"crossref","unstructured":"Kim DH, Stark WJ, O\u2019Brien TP, et al. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. Ophthalmology 2005;112: 1992\u20136","DOI":"10.1016\/j.ophtha.2005.06.017"},{"key":"CIT0021","doi-asserted-by":"crossref","unstructured":"Schlech BA, Blondeau J. Future of ophthalmic anti-infective therapy and the role of moxifloxacin ophthalmic solution 0.5% (VIGAMOX). Surv Ophthalmol 2005;50(Suppl 1):S64\u20137","DOI":"10.1016\/j.survophthal.2005.05.005"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.01.061"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2006.09.015"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200602000-00012"},{"key":"CIT0025","doi-asserted-by":"crossref","unstructured":"Solomon R, Donnenfeld ED, Perry HD, et al. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Ophthalmology 2005;112: 466\u20139","DOI":"10.1016\/j.ophtha.2004.09.029"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1097\/01.ico.0000157423.78275.a2"},{"key":"CIT0027","first-page":"523","volume":"24","author":"Notivol R","year":"2004","journal-title":"Whitling A, et al.; and the International TobraDex Study Group. Prophylactic effectiveness of tobramycindexamethasone eye drops compared with tobramycin\/vehicle eye drops in controlling post-surgical inflammation in cataract patients: prospective, randomised, double-masked, two-arm, parallel-group, placebo-controlled, multicentre study. Clin Drug Invest"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.12.1380"},{"key":"CIT0029","first-page":"2137","volume":"31","author":"Price MO","year":"2005","journal-title":"3% and moxifloxacin 0.5% ophthalmic solutions on human corneal epithelium following 2 dosing regimens. J Cataract Refract Surg"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1097\/01.ico.0000220777.70981.46"},{"key":"CIT0031","first-page":"689","volume":"19","author":"Renard G","year":"1996","journal-title":"J Fr Ophthalmol"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1177\/112067219700700204"},{"key":"CIT0033","first-page":"13","volume":"6","author":"Shepherd WF","year":"1998","journal-title":"Diclofenac\u2013gentamicin versus Gentamicin Study Group. A clinical evaluation of diclofenac\u2013gentamicin combination eye drops in the control of inflammation after cataract surgery. Ocul Immunol Inflamm"},{"key":"CIT0034","doi-asserted-by":"crossref","unstructured":"Barraquer RI, Alvarez de Toledo JP, Montane D, et al. Fixed-dose combination of 0.1% diclofenac plus 0.3% tobramycin ophthalmic solution for inflammation after cataract surgery: a randomized, comparative, active treatment-controlled trial. Eur J Ophthalmol 1998;8: 173\u20138","DOI":"10.1177\/112067219800800310"},{"key":"CIT0035","first-page":"58","volume":"21","author":"Russo S","year":"2007","journal-title":"Efficacy and safety after cataract surgery. Eye"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079907X242629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T06:06:14Z","timestamp":1737871574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079907X242629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,1]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,1,1]]}},"alternative-id":["10.1185\/030079907X242629"],"URL":"https:\/\/doi.org\/10.1185\/030079907x242629","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,1]]}}}